XML 17 R8.htm IDEA: XBRL DOCUMENT
v3.22.1

Earnings Per Share | 6 Months Ended
--- | ---
Mar. 31, 2022
Earnings Per Share [Abstract] |
Earnings per Share | Earnings per Share The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows:
| Three Months Ended March 31, |  | Six Months Ended March 31,
| 2022 |  | 2021 |  | 2022 |  | 2021
Average common shares outstanding | 285,243 |  |  | 291,095 |  |  | 284,961 |  |  | 290,839 |
Dilutive share equivalents from share-based plans | 2,003 |  |  | 2,452 |  |  | 2,215 |  |  | 2,660 |
Dilutive share equivalents from Series C preferred shares (a) | 53 |  |  | — |  |  | 26 |  |  | — |
Average common and common equivalent shares outstanding – assuming dilution | 287,299 |  |  | 293,547 |  |  | 287,202 |  |  | 293,499 |
Share equivalents excluded from the diluted shares outstanding calculation: |  |  |  |  |  |  |
Mandatory convertible preferred stock (b) | 5,639 |  |  | 6,169 |  |  | 5,639 |  |  | 6,169 |
Share-based plans (c) | — |  |  | 773 |  |  | 676 |  |  | 773 |
(a)Represents dilutive share equivalents from Series C preferred shares that temporarily replaced shares of common stock held in trusts to adhere to trust requirements until the Company’s spin-off of its Diabetes Care business on April 1, 2022 was completed. (b)Excluded from the diluted shares outstanding calculation because the result would have been antidilutive. (c)Excluded from the diluted earnings per share calculation as the exercise prices of these awards were greater than the average market price of the Company’s common shares.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration